Trends in the proportion (%) of methicillin-susceptible Staphylococcus aureus (MSSA)[the proportion of antimicrobial resistance in humans]
![Trends in the proportion (%) of methicillin-susceptible Staphylococcus aureus (MSSA)[the proportion of antimicrobial resistance in humans]](https://amr-onehealth.ncgm.go.jp/en/wp-content/uploads/2018/03/0701Methicillin-susceptible-Staphylococcus-aureusMSSAèæ§çã®æ¨ç§»-G.png)
A statistical information site that deepens
the understanding of AMR (drug resistance) and one health
A statistical information site that deepens
the understanding of AMR (drug resistance) and one health
![Trends in the proportion (%) of methicillin-resistant Staphylococcus aureus (MRSA)[the proportion of antimicrobial resistance in humans]](https://amr-onehealth.ncgm.go.jp/en/wp-content/uploads/2018/03/0801Methicillin-resistant-Staphylococcus-aureusMRSA-ã®èæ§çã®æ¨ç§»-G.png)
![The proportion (%) of patients with MRSA among all patients with Staphylococcus aureus (S. aureus) All participating medical institutions[the proportion of antimicrobial resistance in humans]](https://amr-onehealth.ncgm.go.jp/en/wp-content/uploads/2018/03/0901MRSAåé¢æ£è
ã®å
¨Staphylococcus-aureusS.-aureusåé¢æ£è
ã«å-ããå²å-G.png)
![The proportion (%) of patients with MRSA among all patients with Staphylococcus aureus (S. aureus) Participating medical institutions with 200 or more beds[the proportion of antimicrobial resistance in humans]](https://amr-onehealth.ncgm.go.jp/en/wp-content/uploads/2019/03/0902MRSAåé¢æ£è
ã®å
¨Staphylococcus-aureusS.-aureusåé¢æ£è
ã«å-ããå²å-G.png)
![The proportion (%) of patients with MRSA among all patients with Staphylococcus aureus (S. aureus) Participating medical institutions with fewer than 200 beds[the proportion of antimicrobial resistance in humans]](https://amr-onehealth.ncgm.go.jp/en/wp-content/uploads/2019/03/0903MRSAåé¢æ£è
ã®å
¨Staphylococcus-aureusS.-aureusåé¢æ£è
ã«å-ããå²å-G.png)
![Trends in the proportion of (%) of patients with MRSA among all patients with Staphylococcus aureus (S. aureus) and oral penicillins consumption caluated from the sales data[the proportion of antimicrobial resistance and antimicrobial consumption in humans]](https://amr-onehealth.ncgm.go.jp/en/wp-content/uploads/2018/03/0951MRSAåé¢æ£è
ã®å
¨S.-aureusåé¢æ£è
ã«å-ããå²åã¨è²©å£²é-G.png)
![Trends in the proportion of (%) of patients with MRSA among all patients with Staphylococcus aureus (S. aureus) and parental penicillins consumption calculated from the sales data[the proportion of antimicrobial resistance and antimicrobial consumption in humans]](https://amr-onehealth.ncgm.go.jp/en/wp-content/uploads/2018/03/0952MRSAåé¢æ£è
ã®å
¨S.-aureusåé¢æ£è
ã«å-ããå²åã¨è²©å£²é-G.png)
![Trends in the proportion of (%) of patients with MRSA among all patients with Staphylococcus aureus (S. aureus) and oral Cephalosporins consumption calculated from the sales data[the proportion of antimicrobial resistance and antimicrobial consumption in humans]](https://amr-onehealth.ncgm.go.jp/en/wp-content/uploads/2018/03/0953MRSAåé¢æ£è
ã®å
¨S.-aureusåé¢æ£è
ã«å-ããå²åã¨è²©å£²é-G.png)
![Trends in the proportion of (%) of patients with MRSA among all patients with Staphylococcus aureus (S. aureus) and parental Cephalosporins consumption calculated from the data[the proportion of antimicrobial resistance and antimicrobial consumption in humans]](https://amr-onehealth.ncgm.go.jp/en/wp-content/uploads/2018/03/0954MRSAåé¢æ£è
ã®å
¨S.-aureusåé¢æ£è
ã«å-ããå²åã¨è²©å£²é-G.png)
![Trends in the proportion of (%) of patients with MRSA among all patients with Staphylococcus aureus (S. aureus) and oral Fluoroquinolones consumption calculated from the sales data[the proportion of antimicrobial resistance and antimicrobial consumption in humans]](https://amr-onehealth.ncgm.go.jp/en/wp-content/uploads/2018/03/0955MRSAåé¢æ£è
ã®å
¨S.-aureusåé¢æ£è
ã«å-ããå²åã¨è²©å£²é-G.png)
![Trends in the proportion of (%) of patients with MRSA among all patients with Staphylococcus aureus (S. aureus) and parental Fluoroquinolones consumption calculated from the sales data[the proportion of antimicrobial resistance and antimicrobial consumption in humans]](https://amr-onehealth.ncgm.go.jp/en/wp-content/uploads/2018/03/0956MRSAåé¢æ£è
ã®å
¨S.-aureusåé¢æ£è
ã«å-ããå²åã¨è²©å£²é-G.png)